Stock of Interest

Posted On: July 18, 2023

Stock Report : NATCOPHARM (NSE) 17 Jul 2023

Natco Pharma is an Indian multinational pharmaceutical company based in Hyderabad. Founded in 1981, it specializes in manufacturing finished dosage formulations, active pharmaceutical ingredients, and crop health science products. The company also offers contract manufacturing services. With a workforce of around 4,025 employees, Natco Pharma generated revenue of 2,811 crores INR (US$350 million) in the fiscal year 2023. Its subsidiaries include Natco Organics Limited and Natco Pharma. 

xCalData predicts NATCOPHARM will continue its Bullish phase over the next five days and trend in the range of 701 to 734. 

In comparison to the previous month, the price of the stock has experienced an increase of 15.99% indicating a bullish. 

Majority of the technical ratios trend towards Bullish side of the spectrum. Only Trendline indicator indicates bearish view. 

Collectively, xCalData suggests the stock would be in Bullish zone for next 5 days. 

The Stock has doubled twice since 26 Feb 2015 and took an average of 3.2 years to double. 

The stock has shown seasonality trend in the past. 

Reviewing the returns for the past 5 years for the same week, we see the stock has given positive returns in 4 years in the past. 

#xCalData is an exceptional app available for Android devices that offers unbiased insights into stocks, allowing investors to make informed decisions. With its user-friendly interface and comprehensive features, xCalData provides a valuable resource for anyone interested in the stock market.  Download the app from google play. 

For Actionable Intelligence, subscribe to xCalData app on Android devices: https://tinyurl.com/downloadxCalData.